2009.05.07 Weekly Broadcast Email

 The following updates were made the website for the week of May 4, 2009.

Adverse Events:
The following adverse event was reported during the month of April. A PDF of the AE document has been attached to this email and a summary of the event can be found on the adverse event page of the website.
98308: AE 21
Accrual Update:
In the month of April, 15 patients were accrued to CCCWFU CCOP Research Base trials. Wake Forest was the top accruing site with 7 patients. See the Research Base website home page for accrual information on each site.

Reminder:
97106 (Randomized Study to Determine whether ArginMax Improves the Sexual Function and Quality of Life in Female Cancer Survivors) only has 15 minority accrual slots open for patient accruals. We would like to see this study close by the end of the summer, so if you have patients that may be eligible for this study, please try and get them registered by then.



Featured Study:
97405 (Randomized Study of Soy Protein and Effexor on Vasomotor Symptoms of Men with Prostate Cancer)
Since the closure of the COLD-fX, is your site looking for a new study? Then consider enrolling patients in the Soy/Effexor trial.
Our goal is to have 125 patients registered by June 1st. Click here to download the protocol documents, view slide show presentations, and more. Consider joining the Research Base in reaching its June 1st goal!

Quick Reference

Research Base

Fax 336-716-6275
Phone 336-716-0891

2000 West First Street
Protocol Information Office
Suite 101
Winston-Salem, NC 27104
Find A Doctor Ways to Give
Last Updated: 08-19-2009
USNWR 2013-2014Magnet Hospital RecognitionConsumer Choice2014 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.